Immunohistochemistry demonstrated increased expression of CD40, CD40L, MMP-9, and MCP-1 in atherosclerotic plaques in the moderate/severe OSA group (Table 2, Table S2, Figure 1). This evidence concerns the gene CD40 and obstructive sleep apnea syndrome.